271 related articles for article (PubMed ID: 30587634)
1. Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.
Park HJ; Ryu HS; Kim K; Shin KH; Han W; Noh DY
In Vivo; 2019; 33(1):263-269. PubMed ID: 30587634
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract][Full Text] [Related]
3. Phyllodes tumor of the breast.
Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
[TBL] [Abstract][Full Text] [Related]
4. Malignant phyllodes tumor of the breast: treatment and prognosis.
Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
[TBL] [Abstract][Full Text] [Related]
5. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.
Gnerlich JL; Williams RT; Yao K; Jaskowiak N; Kulkarni SA
Ann Surg Oncol; 2014 Apr; 21(4):1222-30. PubMed ID: 24306659
[TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
8. Effect of postoperative time for adjuvant radiotherapy in malignant phyllodes tumor: An institutional experience.
Yogi V; Singh OP; Malviya A; Ghori HU
J Cancer Res Ther; 2018; 14(5):1054-1058. PubMed ID: 30197347
[TBL] [Abstract][Full Text] [Related]
9. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
10. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.
Demian GA; Fayaz S; El-Sayed Eissa H; Nazmy N; Samir S; George T; El-Sherify M; Abuzalouf S
J Egypt Natl Canc Inst; 2016 Dec; 28(4):243-248. PubMed ID: 27406381
[TBL] [Abstract][Full Text] [Related]
12. Management of malignant and borderline phyllodes tumors of the breast: our experience.
Zervoudis S; Xepapadakis G; Psarros N; Bothou A; Tsikouras P; Galazios G; Kontogianni P; Papazian M; Navrozoglou I; Iatrakis G; Paschopoulos M
J BUON; 2019; 24(4):1521-1525. PubMed ID: 31646802
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumors of the breast: Adjuvant radiation therapy revisited.
Boutrus RR; Khair S; Abdelazim Y; Nasr S; Ibraheem MH; Farahat A; El Sebaie M
Breast; 2021 Aug; 58():1-5. PubMed ID: 33865208
[TBL] [Abstract][Full Text] [Related]
14. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
[TBL] [Abstract][Full Text] [Related]
15. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of ipsilateral breast tumor recurrence.
Kolben T; Schwarz TM; Goess C; Blume C; Degenhardt T; Engel J; Wuerstlein R; Ditsch N; Harbeck N; Kahlert S
Int J Surg; 2015 Nov; 23(Pt A):141-6. PubMed ID: 26449651
[TBL] [Abstract][Full Text] [Related]
17. Breast conserving surgery in combination with intraoperative radiotherapy after previous external beam therapy: an option to avoid mastectomy.
Thangarajah F; Heilmann J; Malter W; Kunze S; Marnitz S; Mallmann P; Wenz F; Sperk E
Breast Cancer Res Treat; 2018 Apr; 168(3):739-744. PubMed ID: 29335922
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Radiotherapy and Histological Risk Factors on Outcomes in Malignant Phyllodes Tumors.
Wong RX; Koh YS; Wong FY; Kusumawidjaja G; Ng WL; Yeo RMC; Farid M; Sheng Chan JY; Yan Z; Gudi MA; Tan PH
Clin Breast Cancer; 2020 Dec; 20(6):e695-e700. PubMed ID: 32636151
[TBL] [Abstract][Full Text] [Related]
19. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
[TBL] [Abstract][Full Text] [Related]
20. Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database.
Chen C; Huang X; Xu Y; Sun Q
Medicine (Baltimore); 2023 Mar; 102(12):e33326. PubMed ID: 36961178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
